Company Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging
October 16, 2014 at 16:30 PM EDT
[PR Newswire] – MARLBOROUGH, Mass., Oct. 16, 2014 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the ACCOLADE TM pacemaker family. When implanted with the company’s INGEVITY … . . . → Read More: Company Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging Similar Articles: Market Update (NYSE:BSX): Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System Market Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific To Participate In 2014 Bank Of America Merrill Lynch Global Healthcare Conference Stock Update: Boston Scientific Corporation (NYSE:BSX) – Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs
